New Results
Malignant liver cancers have distinct myeloid-derived suppressor cell signatures
View ORCID ProfileDefne Bayik, Emily Serbinowski, View ORCID ProfileAdam Lauko, Gustavo A. Roversi, View ORCID ProfileLou-Anne Acevedo-Moreno, Christopher Lanigan, View ORCID ProfileMushfig Orujov, Daniel J. Silver, View ORCID ProfileJ. Mark Brown, View ORCID ProfileDaniela S. Allende, Federico N. Aucejo, View ORCID ProfileJustin D. Lathia
doi: https://doi.org/10.1101/554600
Defne Bayik
1Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA
Emily Serbinowski
1Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA
Adam Lauko
1Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA
Gustavo A. Roversi
1Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA
Lou-Anne Acevedo-Moreno
2Department of General Surgery, Cleveland Clinic, Cleveland, OH 44195, USA
Christopher Lanigan
3Department of Pathology, Cleveland Clinic, Cleveland, OH 44195, USA
Mushfig Orujov
3Department of Pathology, Cleveland Clinic, Cleveland, OH 44195, USA
4Department of Pathological Anatomy, Azerbaijan Medical University, Baku, AZ 1022, Azerbaijan
Daniel J. Silver
1Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA
J. Mark Brown
1Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA
Daniela S. Allende
3Department of Pathology, Cleveland Clinic, Cleveland, OH 44195, USA
Federico N. Aucejo
2Department of General Surgery, Cleveland Clinic, Cleveland, OH 44195, USA
Justin D. Lathia
1Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA
Article usage
Posted February 19, 2019.
Malignant liver cancers have distinct myeloid-derived suppressor cell signatures
Defne Bayik, Emily Serbinowski, Adam Lauko, Gustavo A. Roversi, Lou-Anne Acevedo-Moreno, Christopher Lanigan, Mushfig Orujov, Daniel J. Silver, J. Mark Brown, Daniela S. Allende, Federico N. Aucejo, Justin D. Lathia
bioRxiv 554600; doi: https://doi.org/10.1101/554600
Malignant liver cancers have distinct myeloid-derived suppressor cell signatures
Defne Bayik, Emily Serbinowski, Adam Lauko, Gustavo A. Roversi, Lou-Anne Acevedo-Moreno, Christopher Lanigan, Mushfig Orujov, Daniel J. Silver, J. Mark Brown, Daniela S. Allende, Federico N. Aucejo, Justin D. Lathia
bioRxiv 554600; doi: https://doi.org/10.1101/554600
Subject Area
Subject Areas
- Biochemistry (11752)
- Bioengineering (8752)
- Bioinformatics (29200)
- Biophysics (14974)
- Cancer Biology (12096)
- Cell Biology (17411)
- Clinical Trials (138)
- Developmental Biology (9421)
- Ecology (14182)
- Epidemiology (2067)
- Evolutionary Biology (18308)
- Genetics (12245)
- Genomics (16803)
- Immunology (11869)
- Microbiology (28097)
- Molecular Biology (11594)
- Neuroscience (60969)
- Paleontology (451)
- Pathology (1871)
- Pharmacology and Toxicology (3238)
- Physiology (4959)
- Plant Biology (10427)
- Synthetic Biology (2886)
- Systems Biology (7340)
- Zoology (1651)